Relationships of cholesterol levels with cardiovascular risk weaken with advancing age， and use of statins for primary prevention in older people remains controversial. Among the 17802 apparently h.....
Saely CH， Rein P， Vonbank A， Drexel H.Abstract BACKGROUND: The JUPITER trial has recently demonstrated an outstanding reduction of cardiovascular events by 20 mg rosuvastatin/day in subjects with high CRP.....
Yoshinobu Onuma; Patrick W Serruys， The ABSORB Investigators Thorax Cntr， Erasmus MC， Rotterdam， Netherlands Background: Bioabsorbable polymer drug-eluting stents (DES) are an alternative approach .....
关注公众号
安卓客户端
